Looking Past the Pandemic

The Biohealth Industry’s response to the novel coronavirus has been essential and inspiring.  As our country slowly begins to return to a new “normal”, this panel reflects on how our industry has changed, what we have learned, and how we use this knowledge and experience as we move confidently into the future.

Professor of Pathology and Laboratory Medicine University of Wisconsin- Madison Dave O’Connor is a UW Medical Foundation Professor of Pathology and Laboratory Medicine at the University of Wisconsin-Madison and Professorial Fellow at the University of Melbourne. His laboratory studies the interplay between viral pathogenesis, genomics, and immunity. In Dane County, Wisconsin, where the University of…

View details

Director of Applied Markets Business Unit Promega Sameer Moorji is the Director of Applied Markets Business Unit at Promega Corporation. His team is responsible for the strategic direction and commercialization of differentiating technologies to serve the needs of customers in Environmental, Agricultural, Food and Veterinary Sciences. Most recently, the team developed a workflow solution for…

View details

Chief Executive Officer Promentis Pharmaceuticals Daniel Lawton is the Chief Executive Officer of Promentis Pharmaceuticals. Mr. Lawton has more than 20 years of experience in the pharmaceutical and life sciences industry. Previously, Mr. Lawton was Group President at Dohmen Life Sciences, and Vice President and General Counsel of Schwarz Pharma, Inc. where he was also…

View details